ELAN Stock: Price, Earnings History and SEC Filings
Elanco Animal Health Incorporated (ELAN) last traded at $23.06, down 0.77% on the latest session and up 3.0% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.34 against an analyst estimate of $0.27, a beat of 25.9%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ELAN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $0.34 | $0.27 | +25.93% |
| Mar 2026 | May 6, 2026 | $0.40 | $0.34 | +17.65% |
| Dec 2025 | Feb 24, 2026 | $0.13 | $0.11 | +18.18% |
| Sep 2025 | Nov 5, 2025 | $0.19 | $0.13 | +46.15% |
ELAN beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How ELAN reacts to earnings
Across its last 8 earnings releases, ELAN moved 11.0% on average the next session, in either direction. It rose after 6 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-05 | Before open | +2.42% |
| 2026-05-06 | Before open | +13.88% |
| 2026-02-24 | Before open | +6.59% |
| 2025-11-05 | Before open | -4.00% |
| 2025-08-07 | Before open | +18.14% |
| 2025-05-07 | Before open | +26.29% |
| 2025-02-25 | Before open | -3.69% |
| 2024-11-07 | Before open | +12.75% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
ELAN financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $4.7B | -$232M | $284M | -4.9% | $-0.47 |
| 2024 | $4.4B | $338M | $394M | 7.6% | $0.68 |
| 2023 | $4.4B | -$1.2B | $131M | -27.9% | $-2.50 |
| 2022 | $4.4B | -$78M | $281M | -1.8% | $-0.16 |
| 2021 | $4.8B | -$483M | $324M | -10.1% | $-0.99 |
| 2020 | $3.3B | -$574M | -$176M | -17.5% | $-1.30 |
| 2019 | $3.1B | $68M | $84M | 2.2% | $0.18 |
| 2018 | $3.1B | $87M | $353M | 2.8% | $0.28 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for ELAN
- 10-Q · Aug 5, 2026
- 8-K · Aug 5, 2026Results of operations, Financial statements and exhibits
- 8-K · May 27, 2026Shareholder vote
- 10-Q · May 6, 2026
- 8-K · May 6, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 8, 2026
- 10-K · Feb 24, 2026
- 8-K · Feb 24, 2026Results of operations, Financial statements and exhibits
- 8-K · Jan 12, 2026Regulation FD disclosure, Financial statements and exhibits
- 8-K · Dec 9, 2025Regulation FD disclosure, Financial statements and exhibits
Insider filing activity
ELAN insiders filed 24 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
ELAN news
- 4 Medical Stocks With a Healthy Shot at Q3 Earnings BeatsOct 30, 2026 · finance.yahoo.com
- Elanco Animal Health Incorporated (ELAN) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseOct 30, 2026 · finance.yahoo.com
- APA Gears Up to Report Q3 Earnings: Here's How It Will FareOct 29, 2026 · finance.yahoo.com
- Encompass Health (EHC) Q3 Earnings and Revenues Top EstimatesOct 28, 2026 · finance.yahoo.com
- Addressing Critical Health Needs Through InnovationOct 27, 2026 · finance.yahoo.com
- Can Zoetis Stock Jump 30%?Oct 26, 2026 · trefis.com
- IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should KnowOct 22, 2026 · finance.yahoo.com
- Elanco Animal Health Appoints Jamie Preston as Chief People OfficerOct 22, 2026 · finance.yahoo.com
About Elanco Animal Health Incorporated
Elanco Animal Health Incorporated (ELAN) is a US-listed public company on NYSE. The SEC classifies its business as Pharmaceutical Preparations. Its fiscal year ends in December.